Wells Fargo & Company Tenaya Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 22,421 shares of TNYA stock, worth $44,842. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,421
Previous 16,435
36.42%
Holding current value
$44,842
Previous $85,000
18.82%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
55.6MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$18.8 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$15.2 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$13.5 Million1.81% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$8.15 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$7.03 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $82.7M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...